Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sharyl J Nass

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Oncology Nursing Forum|January 31, 2002
Mammography to molecular biology: opportunities and obstacles in developing early breast cancer detection methodsSharyl J Nass
Journal of the American Board of Family Medicine : JABFM|November 25, 2024
National Academies of Sciences, Engineering, and Medicine Standing Committee on Primary Care: An Objective Venue to Inform PolicyMarc Meisnere, Sharyl J Nass
Annals of Surgical Oncology|January 7, 2017
Commentary on the Consensus Statement of the American Society of Breast Surgeons on Contralateral Prophylactic MastectomySharyl J Nass, Larissa Nekhlyudov
Science (New York, N.Y.)|March 20, 2004
Research on contraceptivesSharyl J Nass, Jerome F Strauss
Nature Reviews. Drug Discovery|October 2, 2004
Strategies to facilitate the development of new contraceptivesSharyl J Nass, Jerome F Strauss
American Journal of Therapeutics|February 18, 2011
A National Cancer Clinical Trials Network: recommendations from the Institute of MedicineSharyl J Nass, Erin Balogh, John Mendelsohn
The Oncologist|October 19, 2014
Expanding public-private collaborations to enhance cancer drug development: a report of the Institute of Medicine's workshop series, "Implementing a National Cancer Clinical Trials System for the 21st Century"Monica M Bertagnolli, Renzo Canetta, Sharyl J Nass
Journal of the American College of Radiology : JACR|May 31, 2021
Oncologic Errors in Diagnostic Radiology: A 10-Year Analysis Based on Medical Malpractice ClaimsAndrew B Rosenkrantz, Dana Siegal, Jillian A Skillings, et al.
Cancer Biology & Therapy|November 14, 2003
Specific inhibition of DNMT1 by antisense oligonucleotides induces re-expression of estrogen receptor-alpha (ER) in ER-negative human breast cancer cell linesLan Yan, Sharyl J Nass, Dawn Smith, et al.
Journal of the American College of Radiology : JACR|July 9, 2020
National Trends in Oncologic Diagnostic ImagingAndrew B Rosenkrantz, Laura Chaves Cerdas, Danny R Hughes, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Oncology Nursing Forum|January 31, 2002
Mammography to molecular biology: opportunities and obstacles in developing early breast cancer detection methodsSharyl J Nass
Journal of the American Board of Family Medicine : JABFM|November 25, 2024
National Academies of Sciences, Engineering, and Medicine Standing Committee on Primary Care: An Objective Venue to Inform PolicyMarc Meisnere, Sharyl J Nass
Annals of Surgical Oncology|January 7, 2017
Commentary on the Consensus Statement of the American Society of Breast Surgeons on Contralateral Prophylactic MastectomySharyl J Nass, Larissa Nekhlyudov
Science (New York, N.Y.)|March 20, 2004
Research on contraceptivesSharyl J Nass, Jerome F Strauss
Nature Reviews. Drug Discovery|October 2, 2004
Strategies to facilitate the development of new contraceptivesSharyl J Nass, Jerome F Strauss
American Journal of Therapeutics|February 18, 2011
A National Cancer Clinical Trials Network: recommendations from the Institute of MedicineSharyl J Nass, Erin Balogh, John Mendelsohn
The Oncologist|October 19, 2014
Expanding public-private collaborations to enhance cancer drug development: a report of the Institute of Medicine's workshop series, "Implementing a National Cancer Clinical Trials System for the 21st Century"Monica M Bertagnolli, Renzo Canetta, Sharyl J Nass
Journal of the American College of Radiology : JACR|May 31, 2021
Oncologic Errors in Diagnostic Radiology: A 10-Year Analysis Based on Medical Malpractice ClaimsAndrew B Rosenkrantz, Dana Siegal, Jillian A Skillings, et al.
Cancer Biology & Therapy|November 14, 2003
Specific inhibition of DNMT1 by antisense oligonucleotides induces re-expression of estrogen receptor-alpha (ER) in ER-negative human breast cancer cell linesLan Yan, Sharyl J Nass, Dawn Smith, et al.
Journal of the American College of Radiology : JACR|July 9, 2020
National Trends in Oncologic Diagnostic ImagingAndrew B Rosenkrantz, Laura Chaves Cerdas, Danny R Hughes, et al.
Pageof 3